BRIEF published on 10/28/2024 at 08:05, 1 year 9 months ago Ondine Biomedical fait progresser la commercialisation de Steriwave Ondine Biomedical Technologie Steriwave Résistance Aux Antimicrobiens Innovation Dans Le Domaine De La Santé Infections Associées Aux Soins De Santé
BRIEF published on 10/28/2024 at 08:05, 1 year 9 months ago Ondine Biomedical Advances Steriwave Commercialization Antimicrobial Resistance Ondine Biomedical Steriwave Technology Healthcare-associated Infections Innovation In Healthcare
PRESS RELEASE published on 10/28/2024 at 08:00, 1 year 9 months ago Ondine Continues Commercial Growth Ondine Biomedical Inc. provides updates on the commercial roll-out of its Steriwave® nasal decolonization technology, reducing healthcare-associated infections with light-activated treatment Ondine Biomedical Inc. Nasal Decolonization Steriwave Healthcare-associated Infections Antimicrobial Treatments
BRIEF published on 10/23/2024 at 08:05, 1 year 9 months ago Ondine Biomedical Inc. lance le projet pilote Steriwave au King's College Hospital Steriwave Ondine Biomedical Innovation Dans Le Domaine De La Santé Hôpital King's College Traitement Antimicrobien
BRIEF published on 10/23/2024 at 08:05, 1 year 9 months ago Ondine Biomedical Inc. Launches Steriwave Pilot at King's College Hospital Steriwave Healthcare Innovation Ondine Biomedical Antimicrobial Treatment King's College Hospital
PRESS RELEASE published on 10/23/2024 at 08:00, 1 year 9 months ago Ondine Biomedical Inc. Announces King's College Hospital to Run Steriwave Pilot Ondine Biomedical Inc. collaborates with King's College Hospital to pilot Steriwave® light-activated antimicrobial tech for preventing HAIs. Steriwave rapidly eliminates pathogens without resistance Ondine Biomedical Inc. Steriwave Hospital-acquired Infections Antimicrobial Technology King's College Hospital
BRIEF published on 09/30/2024 at 11:10, 1 year 10 months ago Ondine Biomedical Reports Robust Growth in H1 2024 Clinical Trials Steriwave Ondine Biomedical Financial Growth Hospital Adoption
BRIEF published on 09/30/2024 at 11:10, 1 year 10 months ago Ondine Biomedical annonce une croissance robuste au premier semestre 2024 Croissance Financière Steriwave Ondine Biomedical Essais Cliniques Adoption À L'hôpital
PRESS RELEASE published on 09/30/2024 at 11:05, 1 year 10 months ago Ondine Biomedical Reports Robust Growth in H1 2024 Ondine Biomedical Inc. reports unaudited operational and financial results for the first half of 2024, showing strong revenue growth and strategic partnerships Financial Performance Ondine Biomedical Inc. Strategic Partnership Clinical Trials Operational Results
BRIEF published on 09/30/2024 at 08:05, 1 year 10 months ago Ondine Biomedical annonce une croissance robuste au premier semestre 2024 Résultats Financiers Ondine Biomedical Essais Cliniques Steriwave® Premier Semestre 2024
Published on 08/11/2026 at 13:30, 30 minutes ago Nextech3D.ai CEO Evan Gappelberg Purchases 250,000 Shares in Open Market
Published on 08/11/2026 at 13:30, 30 minutes ago Algo Grande Provides Phase II Drill Update; Hole 2 Copper Zone Doubles as Hole 3 Delivers Extensive New Interval, Remains Mineralized at Depth
Published on 08/11/2026 at 13:00, 1 hour ago AI/ML Innovations' Subsidiary NeuralCloud Achieves ISO 13485:2016 (MDSAP) Certification
Published on 08/11/2026 at 12:10, 1 hour 50 minutes ago CoTec Holdings Corp. Announces $20m Private Placement Of Unsecured Convertible Debentures
Published on 08/11/2026 at 12:00, 2 hours ago Bitterroot Resources Ltd. - Update on the LM Nickel-Copper Project, Michigan, USA
Published on 08/11/2026 at 13:40, 19 minutes ago Julius Meinl Living completes the sale of EUR 7.6 million of 2024 / 2029 notes
Published on 08/11/2026 at 13:05, 54 minutes ago Vaderis Therapeutics Announces Oversubscribed $152 Million Series B Financing and Initiation of the Global Phase 3 HEROIC Study of Engasertib for Hereditary Hemorrhagic Telangiectasia
Published on 08/11/2026 at 12:40, 1 hour 19 minutes ago Green Street Launches Its MCP Server, Powered by GreenStreetAI™, Connecting CRE Intelligence Directly to Corporate Instances of Claude, ChatGPT, Gemini, and Other AI Platforms
Published on 08/11/2026 at 12:30, 1 hour 30 minutes ago Immunic, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Published on 08/10/2026 at 18:00, 20 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 20 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Published on 08/10/2026 at 17:45, 20 hours 15 minutes ago Déclaration hebdomadaire de rachat d'actions
Published on 08/10/2026 at 11:53, 1 day 2 hours ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
